These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 24044963)
1. Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells. Li J; Andreyev O; Chen M; Marco M; Iwase H; Long C; Ayares D; Shen Z; Cooper DK; Ezzelarab MB Cell Immunol; 2013; 285(1-2):23-30. PubMed ID: 24044963 [TBL] [Abstract][Full Text] [Related]
2. Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses. Ezzelarab M; Ezzelarab C; Wilhite T; Kumar G; Hara H; Ayares D; Cooper DK Xenotransplantation; 2011; 18(3):183-95. PubMed ID: 21696448 [TBL] [Abstract][Full Text] [Related]
3. Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties. Kumar G; Hara H; Long C; Shaikh H; Ayares D; Cooper DK; Ezzelarab M Cytotherapy; 2012 Apr; 14(4):494-504. PubMed ID: 22264190 [TBL] [Abstract][Full Text] [Related]
4. Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs. Lee W; Hara H; Ezzelarab MB; Iwase H; Bottino R; Long C; Ramsoondar J; Ayares D; Cooper DK Xenotransplantation; 2016 Mar; 23(2):137-50. PubMed ID: 26988899 [TBL] [Abstract][Full Text] [Related]
5. Initial study of α1,3-galactosyltransferase gene-knockout/CD46 pig full-thickness corneal xenografts in rhesus monkeys. Dong X; Hara H; Wang Y; Wang L; Zhang Y; Cooper DK; Dai Y; Pan Z Xenotransplantation; 2017 Jan; 24(1):. PubMed ID: 28054735 [TBL] [Abstract][Full Text] [Related]
6. Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig Cells. Zhang Z; Hara H; Long C; Iwase H; Qi H; Macedo C; Mangiola M; Zeevi A; Ezzelarab M; Ayares D; Cooper DKC; Wijkstrom M Transplantation; 2018 May; 102(5):e195-e204. PubMed ID: 29266033 [TBL] [Abstract][Full Text] [Related]
7. Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs. Hara H; Koike N; Long C; Piluek J; Roh DS; SundarRaj N; Funderburgh JL; Mizuguchi Y; Isse K; Phelps CJ; Ball SF; Ayares DL; Cooper DK Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5278-86. PubMed ID: 21596821 [TBL] [Abstract][Full Text] [Related]
8. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002 [TBL] [Abstract][Full Text] [Related]
9. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Lin YJ; Hara H; Tai HC; Long C; Tokita D; Yeh P; Ayares D; Morelli AE; Cooper DK Transplantation; 2008 Nov; 86(10):1452-62. PubMed ID: 19034017 [TBL] [Abstract][Full Text] [Related]
10. Human T-cell proliferation in response to thrombin-activated GTKO pig endothelial cells. Ezzelarab C; Ayares D; Cooper DK; Ezzelarab MB Xenotransplantation; 2012; 19(5):311-6. PubMed ID: 22970807 [TBL] [Abstract][Full Text] [Related]
11. Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition. Iwase H; Ekser B; Hara H; Phelps C; Ayares D; Cooper DK; Ezzelarab MB Xenotransplantation; 2014; 21(1):72-83. PubMed ID: 24188473 [TBL] [Abstract][Full Text] [Related]
12. The effect of Gal expression on pig cells on the human T-cell xenoresponse. Wilhite T; Ezzelarab C; Hara H; Long C; Ayares D; Cooper DK; Ezzelarab M Xenotransplantation; 2012; 19(1):56-63. PubMed ID: 22360754 [TBL] [Abstract][Full Text] [Related]
13. The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation. Li J; Ezzelarab MB; Ayares D; Cooper DK Stem Cell Rev Rep; 2014 Feb; 10(1):79-85. PubMed ID: 24142483 [TBL] [Abstract][Full Text] [Related]
14. A desirable transgenic strategy using GGTA1 endogenous promoter-mediated knock-in for xenotransplantation model. Ko N; Shim J; Kim HJ; Lee Y; Park JK; Kwak K; Lee JW; Jin DI; Kim H; Choi K Sci Rep; 2022 Jun; 12(1):9611. PubMed ID: 35688851 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling. Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379 [TBL] [Abstract][Full Text] [Related]
16. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I. Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752 [TBL] [Abstract][Full Text] [Related]
17. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Hara H; Long C; Lin YJ; Tai HC; Ezzelarab M; Ayares D; Cooper DK Transpl Int; 2008 Dec; 21(12):1163-74. PubMed ID: 18764834 [TBL] [Abstract][Full Text] [Related]